- Home
- AUPH vs RWT Comparison
AUPH vs RWT Comparison
Compare AUPH & RWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUPH | RWT |
|---|---|---|
| Founded | 1993 | 1994 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 743.6M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | AUPH | RWT |
|---|---|---|
| Price | $14.13 | $5.86 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | ★ $17.25 | $7.04 |
| AVG Volume (30 Days) | 910.6K | ★ 1.5M |
| Earning Date | 02-26-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 12.31% |
| EPS Growth | ★ 5075.00 | N/A |
| EPS | ★ 2.07 | N/A |
| Revenue | ★ $283,055,000.00 | N/A |
| Revenue This Year | $17.35 | $26.59 |
| Revenue Next Year | $15.66 | $22.21 |
| P/E Ratio | $6.79 | ★ N/A |
| Revenue Growth | ★ 20.38 | N/A |
| 52 Week Low | $6.83 | $4.68 |
| 52 Week High | $16.54 | $6.97 |
Technical Indicators
Market Signals| Indicator | AUPH | RWT |
|---|---|---|
| Relative Strength Index (RSI) | 44.35 | 45.85 |
| Support Level | $13.52 | $5.81 |
| Resistance Level | $15.23 | $5.90 |
| Average True Range (ATR) | 0.49 | 0.19 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 31.40 | 19.59 |
Price Performance
Historical ComparisonAbout AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About RWT Redwood Trust Inc.
Redwood Trust Inc is a real estate investment trust focused on different areas of housing credit. The company operates in three segments: Sequoia Mortgage Banking includes mortgage loan conduit that acquires residential consumer loans from third-party originators for sale to whole loan buyers and securitization; CoreVest Mortgage Banking segment includes consists of a platform that originates residential investor loans for securitization, sale, or transfer into Redwood Investments portfolio; and Redwood Investments segment consists of organic investments sourced through mortgage banking operations, including securities retained from Sequoia and CoreVest securitization activities. It derives maximum revenue from Redwood Investments segment.